Positioning time in range in diabetes management
Advani A
Diabetologia. 2020;63:242-52
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial
Fitchett D, Inzucchi SE, Wanner C, et al.
Eur Heart J. 2020;41(2):209-17
Leggi
A new perspective on lowering CV risk from hypoglycaemia
Solis-Herrera C, Sheikh O, Chilton R
Eur Heart J. 2020;41(2):218-20
Leggi
Autoimmunity plays a role in the onset of diabetes after 40 years of age
Rolandsson O, Hampe CS, Sharp SJ, et al.
Diabetologia. 2020;63:266-77
Leggi
Incidence, Risk Factors, and Trends for Postheart Transplantation Diabetes Mellitus
Munshi VN, Saghafian S, Cook CB, et al.
Am J Cardiol. 2020;125(3):436-40
Leggi
Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European observational multicentre study)
Creta A, Providência R, Adragao P, et al.
Am J Cardiol. Pub. online 30 December 2019
Leggi
Incidence, Risk Factors, and Trends for Postheart Transplantation Diabetes Mellitus
Munshi VN, Saghafian S, Cook CB, et al.
Am J Cardiol. 2020;125(3):436-40
Leggi
Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up
Yu Y, Arah OA, Liew Z, et al.
BMJ. 2019;367:l6398
Leggi
Preterm birth and risk of type 1 and type 2 diabetes:a national cohort study
Crump C, Sundquist J, Sundquist K
Diabetologia. Pub. online 3 December 2019
Leggi
Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus
Colombo M, McGurnaghan SJ, Bell S, et al.
Diabetologia. Pub. online 5 December 2019
Leggi